Service Design and Delivery

Group Leader: Tom Marshall


The group focus is on evaluation of health service delivery in both primary and secondary care and on developing methodologies for evaluation of these technologies.

Our Research Group

The research group combines expertise in health service evaluation, assessment of patient reported outcomes, quality improvement in primary care and use of routine data for health service evaluation. The research includes methodological developments in the measurement of patient reported outcomes, study design and the use of routine data for outcome measurement.

Current Projects

Research projects in secondary care include:

  • Investigation of clinical handovers
  • Evaluation of long term outcomes after athroplasty
  • Investigation of cardiovascular outcomes after arthroplasty
  • Evaluation of the implementation of critical care outreach in a developing country.

Research projects in primary care include:

  • Investigation of quality improvement in primary care (doctoral thesis);
  • Evaluation of a telephone call back system of primary care access using routine data;
  • Evaluation of patient factors influencing prescribing of statins in primary care;
  • Investigation of the feasibility of using information technology to assist colorectal cancer diagnosis
  • Methodological developments include the use of linked routine primary and secondary care data to assess outcomes after surgical interventions; the use of stepped wedge cluster randomised controlled trials for evaluation of service changes; developments in assessment of patient reported outcomes

Recent Publications

Yao GL, Novielli N, Manaseki-Holland S, Chen YF, van der Klink M, Barach P, Chilton PJ, Lilford RJ; European HANDOVER Research Collaborative. Evaluation of a predevelopment service delivery intervention: an application to improve clinical handovers. BMJ Qual Saf. 2012 Dec;21 Suppl 1:i29-38. doi: 10.1136/bmjqs-2012-001210. Epub 2012 Sep 13.

Kyte D, Draper H, Calvert M. Patient-reported outcome alerts: ethical and logistical considerations in clinical trials. JAMA. 2013 Sep 25;310(12):1229-30. doi: 10.1001/jama.2013.277222.

Wu J, Yao GL, Zhu S, Mohammed MA. Marshall T. Patient factors influencing the prescribing of lipid lowering drugs for primary prevention of cardiovascular disease in UK general practice: a national retrospective cohort study PLoS One 2013 8(7): e67611.

Marshall T, Caley M, Hemming K, Gill P, Gale N, Jolly K. Mixed methods evaluation of targeted case finding for cardiovascular disease prevention using a stepped wedged cluster RCT BMC Public Health 2012; 12:908. doi:10.1186/1471-2458-12-908

Calvert M, Blazeby J, Altman DG, Revicki DA, Moher D, Brundage MD; CONSORT PRO Group. Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. JAMA. 2013 Feb 27;309(8):814-22. doi: 10.1001/jama.2013.879.

McMinn DJ, Snell KI, Daniel J, Treacy RB, Pynsent PB, Riley RD. Mortality and implant revision rates of hip arthroplasty in patients with osteoarthritis: registry based cohort study. BMJ. 2012 Jun 14;344:e3319. doi: 10.1136/bmj.e3319.


Principal Investigator(s)
Tom Marshall
Melanie Calvert
Semira Maneseki-Holland  
Gavin Rudge
Ronan Ryan
Elaine Kidney
Thomas Keeley
Sabrina Grant

Ryan Irwin
Alireza Jeddian
Grace Moran
Derek Kyte
Rebecca Mercieca- Bebber (affiliated student syt the University of Sydney)